World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
77
Citations
18592
World Ranking
18538
National Ranking
617

Michel Henry-Amar publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Michel Henry-Amar sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 259 publications — 9th percentile

9% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Michel Henry-Amar D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Michel Henry-Amar sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 77 D-Index — 10th percentile

10% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Michel Henry-Amar is affiliated with the Université de Caen Normandie in France and has contributed mainly to the field of Medicine, with a focus on epidemiology, economics and econometrics, pathology and forensic medicine, oncology, and genetics.

Their research centers on multiple and secondary primary cancers, lymphoma diagnosis and treatment, global cancer incidence and screening, BRCA gene mutations in cancer, thyroid cancer diagnosis and treatment, and economic and financial impacts of cancer as well as health systems, economic evaluations, and quality of life.

Prominent papers authored or coauthored by Michel Henry-Amar include:

  • "Breast cancer risk among thyroid cancer survivors and the role of I-131 treatment," 2022, British Journal of Cancer
  • "Employment situation among long-term Hodgkin lymphoma survivors in Europe: an analysis of patients from nine consecutive EORTC-LYSA trials," 2022, Journal of Cancer Survivorship
  • "Work and education interruption in long-term Hodgkin lymphoma survivors: an analysis among patients from nine EORTC-LYSA trials," 2023, Acta Oncologica
  • "Economic burden in non-Hodgkin lymphoma survivors: The French Lymphoma Study Association SIMONAL cross-sectional study," 2021, Cancer

Frequent coauthors include:

  • Olivier Casasnovas
  • Sidsel J. Juul
  • Sára Rossetti
  • Michal Kiciński
  • Marleen A. E. van der Kaaij

Their work has been published in the following venues:

  • British Journal of Cancer
  • Cancer
  • Journal of Cancer Survivorship
  • Acta Oncologica

Best Publications

  • Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group.

    J M Coindre;P Terrier;N B Bui;F Bonichon

  • Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party.

    Socié G;Henry-Amar M;Bacigalupo A;Hows J

  • Leukemia following Hodgkin's disease.

    Kaldor Jm;Day Ne;Clarke Ea;Van Leeuwen Fe

  • Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease

    Christophe Fermé;Houchingue Eghbali;Jacobus H. Meerwaldt;Chantal Rieux

  • Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients

    HJ Deeg;G Socie;G Schoch;M Henry-Amar

  • Involved-field radiotherapy for advanced Hodgkin's lymphoma.

    Berthe M.P. Aleman;John M.M. Raemaekers;Umberto Tirelli;Roberto Bortolus

  • Low-dose cytarabine versus intensive chemotherapy in the treatment of acute nonlymphocytic leukemia in the elderly.

    H Tilly;S Castaigne;D Bordessoule;P Casassus

  • Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials: 1964-1987.

    M Tubiana;M Henry-Amar;P Carde;JM Burgers

  • Second cancer after the treatment for Hodgkin's disease: a report from the International Database on Hodgkin's Disease

    M. Henry-Amar

  • Combined-Modality Therapy for Clinical Stage I or II Hodgkin's Lymphoma: Long-Term Results of the European Organisation for Research and Treatment of Cancer H7 Randomized Controlled Trials

    Evert M. Noordijk;Patrice Carde;Noëlle Dupouy;Anton Hagenbeek

  • Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials

    Jeremy Franklin;A. Pluetschow;M. Paus;L. Specht

  • Macroscopic lymph-node involvement and neck dissection predict lymph-node recurrence in papillary thyroid carcinoma.

    Stéphane Bardet;Elodie Malville;Jean-Pierre Rame;Emmanuel Babin

  • Clinical stages I and II Hodgkin's disease: a specifically tailored therapy according to prognostic factors.

    P Carde;J M Burgers;M Henry-Amar;M Hayat

  • Increased incidence of solid malignant tumors after bone marrow transplantation for severe aplastic anemia.

    Socié G;Henry-Amar M;Cosset Jm;Devergie A

  • Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patients

    Marc P Andre;Nicolas Mounier;Xavier Leleu;Anne Sonet

  • Quality of Life in Long-Term Survivors of Testicular Cancer: A Population-Based Case-Control Study

    F. Joly;J. F. Héron;L. Kalusinski;P. Bottet

  • Pericarditis and myocardial infarctions after Hodgkin's disease therapy

    J.M. Cosset;M. Henry-Amar;B. Pellae-Cosset;P. Carde

  • Prognostic factors in primary gastrointestinal non-Hodgkin's lymphoma: a multivariate analysis, report of 106 cases, and review of the literature

    Mohamed B. Azab;Michel Henry-Amar;Philippe Rougier;Caroline Bognel

  • Comparison of High-Dose Therapy and Autologous Stem-Cell Transplantation With Conventional Therapy for Hodgkin's Disease Induction Failure: A Case-Control Study

    Marc Andre;Michel Henry-Amar;Jose-Luis Pico;Pauline Brice

  • Treatment-Related Deaths and Second Cancer Risk After Autologous Stem-Cell Transplantation for Hodgkin's Disease

    Marc André;Michel Henry-Amar;Didier Blaise;Philippe Colombat

Frequent Co-Authors

Hanneke C. Kluin-Nelemans
Hanneke C. Kluin-Nelemans University Medical Center Groningen
Hervé Tilly
Hervé Tilly University of Rouen
Umberto Tirelli
Umberto Tirelli National Institutes of Health
Jean-Yves Douillard
Jean-Yves Douillard European Society for Medical Oncology
Gilles Salles
Gilles Salles Memorial Sloan Kettering Cancer Center
Lena Specht
Lena Specht University of Copenhagen
Corinne Haioun
Corinne Haioun Paris-Est Créteil University
Christian Gisselbrecht
Christian Gisselbrecht Université Paris Cité
André Tichelli
André Tichelli University Hospital of Basel
Volker Diehl
Volker Diehl University of Cologne

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Medicine, there are a variety of online degrees and career advancement pathways that can help you meet your educational and professional goals. Many healthcare professionals and aspiring clinicians are seeking flexible options to further their expertise, especially through fully online programs.

CAHME accredited MHA online programs are ideal for those who want to move into healthcare administration or management, providing essential skills in leadership, healthcare policy, and organizational strategy. Nurses looking to advance without time-consuming commutes or in-person requirements may consider online RN-BSN programs without clinicals, offering a streamlined path to the BSN credential.

For advanced nursing practice, you can accelerate your studies with accelerated MSN to DNP programs, designed to fast-track your progress to a terminal nursing degree. Those seeking more flexible options may benefit from the growing selection of DNP programs online, which allow working professionals to balance study, work, and life.

Exploring these accredited programs can open new doors in healthcare—whether you are stepping into administration, broadening your nursing expertise, or reaching the pinnacle of clinical practice.

Best Scientists Citing Michel Henry-Amar

Trending Scientists

Recently Published Articles